Skip To Content

Study ID: BMS CA209-358 HPV H&N; CHECKMATE

Title:

CheckMate 358: Non-Comparative, Two-Cohort, Single-Arm, Open-Label, Phase 1/2 Study of Nivolumab (BMS-936558) in Subjects with Virus-Positive and Virus-Negative Solid Tumors

Location:
Sioux Falls Region
Principal Investigator:
W. Chad Spanos, MD
Disease:
Head and Neck, Gynecologic, Other
Stage:
Phase I/II
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.